Multi-mechanistic analgesia for opioid-induced hyperalgesia
- 19 April 2011
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 37 (2), 125-127
- https://doi.org/10.1111/j.1365-2710.2011.01264.x
Abstract
The phenomenon of opioid-induced hyperalgesia (OIH), an increased sensitivity to pain attributed to the very opioid drugs administered to manage the pain, is well established in animal models, and there is concern that it also occurs in patients. Our objective is to briefly summarize the basic science and clinical evidence about OIH as background to consider the possible benefit of using a multi-mechanistic analgesic approach. It is unclear how OIH occurs, or even why; presumably, it is part of an adaptive response. But development of OIH poses a serious treatment dilemma. OIH differs from tolerance, which also presents as reduced analgesic effect, in that tolerance is addressed by judicious and monitored increase in opioid dose, but OIH would be treated by a decrease in opioid dose. Therefore, it is important to avoid induction of OIH. Currently, it is not clear which patients are at greater risk of developing OIH, or which drugs are at greater risk of producing it. We suggest that multi-mechanistic analgesia, accomplished within either a single drug or a combination of drugs, is a logical approach that might result in a reduced development of OIH.Keywords
This publication has 29 references indexed in Scilit:
- Adverse effects of chronic opioid therapy for chronic musculoskeletal painNature Reviews Rheumatology, 2010
- Opioid hyperalgesiaCurrent Opinion in Supportive & Palliative Care, 2010
- Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphineBritish Journal of Pharmacology, 2009
- Continuous Opioid Therapy (COT) is Rarely Advisable for Refractory Chronic Daily Headache: Limited Efficacy, Risks, and Proposed GuidelinesHeadache: The Journal of Head and Face Pain, 2008
- (–)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic PropertiesJournal of Pharmacology and Experimental Therapeutics, 2007
- Underlying mechanisms of pronociceptive consequences of prolonged morphine exposurePeptide Science, 2005
- Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawalPain, 2003
- Acute Opioid ToleranceAnesthesiology, 2000
- Intraoperative high dose fentanyl induces postoperative fentanyl toleranceCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1999
- Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use statusJournal of Pain and Symptom Management, 1994